Form 4: Arteris Director Claudia Munce Receives RSU Grant

Director Claudia Munce was granted 4,703 restricted stock units as part of her compensation for service on the Arteris, Inc. board.

Summary

• Director Claudia F. Munce received a grant of 4,703 restricted stock units (RSUs) on June 2, 2026.
• Each RSU represents a contingent right to receive one share of Arteris, Inc. common stock.
• The grant was valued at an average trading price of $31.89 per share.
• The reporting person has elected to defer the receipt of the underlying shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard director compensation.

Positives

• The RSU grant aligns the director's interests with those of shareholders through equity-based compensation.

Negatives

• None identified; this is a standard director compensation disclosure.

Risks

• Vesting is contingent upon the reporting person continuing to provide services to the Issuer's Board through the vesting date.

Future Outlook

The RSUs will vest in full on the earlier of the first anniversary of the grant date or immediately before the next annual meeting of stockholders.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard practice in the technology and semiconductor IP sector to ensure long-term alignment with corporate performance.

Comparison to Industry Standards

• The use of RSUs for director compensation is consistent with standard corporate governance practices for publicly traded technology companies.
• The vesting schedule tied to annual meetings is a common mechanism to ensure board continuity.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity grant to a director.

Next Steps

• Vesting of the 4,703 RSUs on the earlier of the first anniversary of the grant or the next annual meeting.

Key Dates

Keywords

Arteris, AIP, Director Compensation, Restricted Stock Units, Insider Transaction, Equity Grant